The Journal of Rheumatology · 2009 · 37 citations · 11 references
MedicineClinical SciencesRadiologyPulmonologyStem Cell TransplantationThoracic RadiologyPulmonary AssessmentPulmonary Function AssessmentPulmonary ImagingSystemic SclerosisDisease Extent QuantificationExtent Of Disease AssessmentHigh-resolution ImagingHigh-resolution TomographyLocalized SclerodermaLung Disease Severity GradingScleroderma TreatmentSystemic Sclerosis Skin Involvement
OBJECTIVE: Using high resolution computed tomography (HRCT), to assess the lung involvement outcome after autologous hematopoietic stem cell transplant (AHSCT) in patients with scleroderma (systemic sclerosis, SSc). METHODS: HCRT scans prospectively performed before (n = 9 patients) and after (n = 47) AHSCT were blindly reviewed by 2 independent investigators using the Wells score. RESULTS: After a median 60 months' followup, the overall disease extent score from HCRT scans decreased from 10 (0-45) to 4 (0-36) (p = 0.04) 6 months after AHSCT, and thereafter increased up to 36 months and stabilized; the modified Rodnan skin score fell (p < 0.05). CONCLUSION: The extent of SSc lung involvement on HRCT rapidly but transiently regressed after AHSCT.
11
Cyclophosphamide versus Placebo in Scleroderma Lung Disease
Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text